Revvity, INC 8-K filings

Revvity, Inc. announced its second quarter 2026 financial results, reporting revenue of $730 million and adjusted EPS of $1.41, while also entering an agreement to divest its China Immunodiagnostics business for up to $200 million.

Revvity, Inc. reported Q1 2026 financial results, including revenue growth and adjusted EPS, while announcing its strategic intent to divest its China Immunodiagnostics business.

Revvity, Inc. shareholders approved an amendment to the company's by-laws allowing holders of 25% of common stock to call special meetings.

Revvity, Inc. reported strong fourth-quarter and full-year 2025 financial results, surpassing expectations and initiating optimistic 2026 guidance.

Revvity, Inc. announced preliminary Q4 and full-year 2025 financial results, expecting to exceed adjusted EPS guidance and reporting solid revenue growth.

Revvity announced third quarter 2025 financial results with $699 million revenue, 1% organic growth, mixed EPS, and raised its full-year adjusted EPS guidance.

Revvity, Inc. announced the appointment of Anita Gonzales as its new Vice President and Chief Accounting Officer, effective October 23, 2025.

Revvity, Inc. reported second-quarter 2025 revenue of $720 million, a 4% increase, and raised its full-year revenue guidance, despite a slight decline in adjusted earnings per share and operating margins.

Revvity reports a solid first quarter with revenue of $665 million and reaffirms its full-year 2025 guidance for organic growth and adjusted EPS.

Revvity, Inc. amends its Articles of Organization and By-laws to implement a majority voting standard for specified corporate actions, effective April 2025.

Revvity announced a 5% increase in fourth-quarter revenue and a full-year revenue of over $2.7 billion, alongside initiating full-year 2025 guidance.

Revvity expects approximately 5% reported and 6% organic revenue growth for the fourth quarter of 2024, with full-year adjusted earnings per share meeting or exceeding prior guidance.

Revvity, Inc. has entered into a new $1.5 billion unsecured revolving credit facility, replacing its previous agreement and extending its financial flexibility.

Revvity announced positive revenue growth and raised its full-year adjusted EPS guidance in its third quarter 2024 financial results.

Revvity announced its second quarter 2024 financial results, reporting a slight revenue decrease but raising its full-year adjusted EPS guidance.

Revvity's first quarter results show a revenue of $650 million with a slight decrease in growth, but the company reaffirms its full-year guidance.

Revvity, Inc. successfully held its annual shareholder meeting on April 23, 2024, where all director nominees were elected and key proposals were approved.

Revvity's fourth quarter results show a revenue decrease, but the company initiates full year 2024 guidance with projected revenue between $2.79-$2.85 billion and adjusted EPS of $4.55-$4.75.

Revvity Inc. has announced the appointment of two new directors to its board, effective February 1, 2024, while also noting that one current director will not seek re-election at the upcoming annual meeting.